View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 28, 2020

Covid-19’s impact on drug contract manufacture in Italy

By Victoria Smith

As of 21 April, one of the worst Covid-19 outbreaks in Europe remains in Italy, with 184,000 individuals diagnosed, as well as 24,650 confirmed fatalities. At the beginning of March, the Italian government applied a lockdown of the predominantly affected Northern regions to stop the spread of infection to the rest of the country. However, this measure was then extended across the country just a few days later.

GlobalData’s Contract Service Provider database shows there are 148 CMOs with Italian facilities; this database has also been used to provide the information for contract service providers shown in this article.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy